Dietary Supplements and Aging Muscle

The University of Alabama at Birmingham

Status: Completed

Conditions: Sarcopenia

Treatments: Dietary Supplement: Juven

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT01057082

F100107001

F31AT005384-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine whether older adults (ages 65-89) who consume the dietary supplement Juven (Abbott Laboratories) versus placebo for 6 months will demonstrate increases in fat-free mass, muscle volume,and physical function.

Enrollment: 36 patients

Sex: All

Ages: 65 to 89 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ages 65-89
• Ambulatory

Exclusion criteria

• Cognitive impairment
• History of renal or hepatic disease
• History of hypotension
• History of peripheral artery disease
• Uncontrolled hypertension
• Uncontrolled diabetes
• Self-reported claustrophobia
• Current smoker
• Steroid or androgen use with the previous 3 months
• Individuals with pacemakers and defibrillators

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

36 participants in 2 patient groups, including a placebo group

Juven

Experimental group

Description:

Participants in the treatment arm will receive the dietary supplement Juven.

Treatment:

Dietary Supplement: Juven

Dietary Supplement: Juven

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Juven

Dietary Supplement: Juven